Shikatani Eric A, Chandy Mark, Besla Rickvinder, Li Cedric C, Momen Abdul, El-Mounayri Omar, Robbins Clinton S, Husain Mansoor
From the Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (E.A.S., M.C., R.B., A.M., O.E.-M., C.S.R., M.H.); and Heart and Stroke Richard Lewar Centre of Excellence, Ted Rogers Centre for Heart Research, McEwen Centre for Regenerative Medicine, and Peter Munk Cardiac Centre (E.A.S., M.C., R.B., C.S.R., M.H.), Department of Laboratory Medicine and Pathobiology (E.A.S., R.B., C.S.R., M.H.), Department of Immunology (C.C.L., C.S.R.), and Department of Medicine (M.C., M.H.), University of Toronto, Ontario, Canada.
Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1367-76. doi: 10.1161/ATVBAHA.115.307116. Epub 2016 May 12.
Vascular smooth muscle cells (VSMCs) are believed to dedifferentiate and proliferate in response to vessel injury. Recently, adventitial progenitor cells were implicated as a source of VSMCs involved in vessel remodeling. c-Myb is a transcription factor known to regulate VSMC proliferation in vivo and differentiation of VSMCs from mouse embryonic stem cell-derived progenitors in vitro. However, the role of c-Myb in regulating specific adult vascular progenitor cell populations was not known. Our objective was to examine the role of c-Myb in the proliferation and differentiation of Sca1(+) adventitial VSMC progenitor cells.
Using mice with wild-type or hypomorphic c-myb (c-myb(h/h)), BrdU (bromodeoxyuridine) uptake and flow cytometry revealed defective proliferation of Sca1(+) adventitial VSMC progenitor cells at 8, 14, and 28 days post carotid artery denudation injury in c-myb(h/h) arteries. c-myb(h/h) cKit(+)CD34(-)Flk1(-)Sca1(+)CD45(-)Lin(-) cells failed to proliferate, suggesting that c-myb regulates the activation of specific Sca1(+) progenitor cells in vivo and in vitro. Although expression levels of transforming growth factor-β1 did not vary between wild-type and c-myb(h/h) carotid arteries, in vitro differentiation of c-myb(h/h) Sca1(+) cells manifested defective transforming growth factor-β1-induced VSMC differentiation. This is mediated by reduced transcriptional activation of myocardin because chromatin immunoprecipitation revealed c-Myb binding to the myocardin promoter only during differentiation of Sca1(+) cells, myocardin promoter mutagenesis identified 2 specific c-Myb-responsive binding sites, and adenovirus-mediated expression of myocardin rescued the phenotype of c-myb(h/h) progenitors.
These data support a role for c-Myb in the regulation of VSMC progenitor cells and provide novel insight into how c-myb regulates VSMC differentiation through myocardin.
血管平滑肌细胞(VSMCs)被认为会在血管损伤时发生去分化并增殖。最近,外膜祖细胞被认为是参与血管重塑的VSMCs的一个来源。c-Myb是一种转录因子,已知其在体内调节VSMC增殖,并在体外调节从小鼠胚胎干细胞衍生的祖细胞分化为VSMCs。然而,c-Myb在调节特定的成年血管祖细胞群体中的作用尚不清楚。我们的目的是研究c-Myb在Sca1(+)外膜VSMC祖细胞增殖和分化中的作用。
利用野生型或低表达c-myb(c-myb(h/h))的小鼠,通过BrdU(溴脱氧尿苷)摄取和流式细胞术发现,在颈动脉剥脱损伤后8天、14天和28天,c-myb(h/h)动脉中Sca1(+)外膜VSMC祖细胞的增殖存在缺陷。c-myb(h/h) cKit(+)CD34(-)Flk1(-)Sca1(+)CD45(-)Lin(-)细胞未能增殖,这表明c-myb在体内和体外调节特定Sca1(+)祖细胞的激活。尽管野生型和c-myb(h/h)颈动脉之间转化生长因子-β1的表达水平没有差异,但c-myb(h/h) Sca1(+)细胞的体外分化表现出转化生长因子-β1诱导的VSMC分化缺陷。这是由心肌肌动蛋白转录激活减少介导的,因为染色质免疫沉淀显示c-Myb仅在Sca1(+)细胞分化期间与心肌肌动蛋白启动子结合,心肌肌动蛋白启动子诱变鉴定出2个特定的c-Myb反应性结合位点,腺病毒介导的心肌肌动蛋白表达挽救了c-myb(h/h)祖细胞的表型。
这些数据支持c-Myb在调节VSMC祖细胞中的作用,并为c-myb如何通过心肌肌动蛋白调节VSMC分化提供了新的见解。